Women's Health News

RSS

Study tests chronotype’s liver link and finds no significant association

Researchers found no significant association between chronotype and FibroScan-derived liver fat or stiffness in 119 medication-naïve adults with overweight or obesity. The exploratory findings cannot exclude smaller effects, particularly for fibrosis, and require confirmation in larger longitudinal studies.

21 Jul 2026

Drinking more water with meals may lead people to eat more

In two randomized crossover studies involving 86 adults, greater water consumption and more frequent switching between bites and sips were associated with higher food and energy intake during beef chili and chicken tikka masala meals. The exploratory secondary analysis cannot establish causality, but it challenges the assumption that drinking water during a meal necessarily curbs eating.

20 Jul 2026

Study reveals geographic gaps in breastfeeding initiation across America

A nationwide analysis led by a UC Riverside (Calif.) professor provides one of the clearest pictures yet of where mothers are least likely to begin breastfeeding their babies in the United States and what circumstances associate with lower rates.

20 Jul 2026

Beetroot juice shows its clearest aerobic benefits in recreational exercisers

A meta-analysis of 38 placebo-controlled trials involving 703 participants found that beetroot juice supplementation was associated with a small improvement in VO2max or VO2peak during aerobic exercise. Benefits were most consistent in recreationally active adults, while evidence in highly trained athletes remained limited and uncertain.

20 Jul 2026

Gut microbial metabolites may shape vulnerability to stress-related mental disorders

Gut microbiome-derived metabolites may influence stress-related mental disorders through neural, immune, endocrine, and epigenetic pathways. Evidence is strongest for depression and preclinical models, while larger longitudinal human studies are needed to establish causality and clinical value.

20 Jul 2026

Prenatal use of certain medications can harm developing fetal brain

A review article by a University of Nebraska Medical Center/Child Health Research Institute research team underscores and describes how altering fundamental brain development processes can be detrimental for the developing baby.

20 Jul 2026

Chrononutrition shows promise for postpartum weight management

New research has found that eating habits that align most closely with a woman's existing routine show promise for losing postpartum baby weight, especially for mothers earlier in the postpartum period.

20 Jul 2026

Filtered coffee links to slower biological aging while instant coffee shows the opposite

Filtered coffee consumption was associated with slower biological aging, while instant coffee was linked to faster aging in UK Biobank participants. The cross-sectional findings do not prove causation, but they suggest that brewing method may influence coffee’s relationship with aging biomarkers.

20 Jul 2026

Fish oil supplementation during pregnancy changes two childhood brain metabolic markers

Randomized maternal fish oil supplementation from pregnancy week 24 lowered offspring cerebral blood flow and oxygen metabolism at age 10 but did not alter precuneus lactate. The small differences resembled a more adult-like metabolic profile, although researchers found no associated cognitive or behavioral benefits.

19 Jul 2026

Vitamin D falls short as an add-on treatment for endometriosis

An eight-week randomized trial of 66 women found that adjunctive vitamin D did not significantly or meaningfully improve endometriosis pain or quality of life compared with placebo during dienogest therapy. The results do not support routine short-term adjunctive supplementation, although the brief trial and absence of post-treatment vitamin D measurements leave longer-term effects uncertain.

19 Jul 2026

Long-term study shows how neighborhood conditions shape women's heart health

Women who live in disadvantaged neighborhoods face worse heart health and experience faster decline as they approach menopause, according to a long-term study led by the Harvard Pilgrim Health Care Institute.

17 Jul 2026

Prenatal acetaminophen use not linked to adverse birth outcomes

There is no statistically significant evidence that taking acetaminophen, also known as Tylenol, during pregnancy has a negative impact on how early a child is born or a child's weight at birth, according to new research led by environmental scientists at the UNC Gillings School of Global Public Health.

17 Jul 2026

Maternal diets high in UPFs may influence children’s health years later

A narrative review of 84 publications links higher ultra-processed food intake during pregnancy and early childhood with poorer diet quality, maternal complications, childhood obesity, and potential immune, metabolic, and neurodevelopmental effects. The authors identify possible microbiome and biopsychosocial pathways but emphasize that the predominantly observational evidence cannot establish causality.

17 Jul 2026

Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge

Higher baseline plasma p-tau217 was associated with greater 5- and 10-year risks of cognitive impairment and faster cognitive decline among 2,684 cognitively unimpaired adults. Very high levels corresponded to an estimated 38% risk at five years, but selected cohorts and limited long-term data mean routine screening and individualized prediction remain premature.

16 Jul 2026

LIG1 loss reveals new treatment strategy for aggressive breast cancer

Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but researchers at Baylor College of Medicine and collaborating institutions have identified a vulnerability in these cells and used it to their advantage.

16 Jul 2026

Weill Cornell Medicine receives DoD grant to target triple-negative breast cancer

Weill Cornell Medicine has received a $2.5 million, three-year grant from the Department of Defense (DoD) to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.

16 Jul 2026